药物对比
Canagliflozin vs Insulin Icodec
比较Canagliflozin（Invokana，口服SGLT2抑制剂）与Insulin Icodec（Awiqli，每周一次胰岛素）治疗2型糖尿病：机制、给药、疗效、副作用及适用性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when considering oral SGLT2 inhibitor therapy versus once-weekly insulin intensification in type 2 diabetes patients.
结论
Choice between Canagliflozin and Insulin Icodec depends on diabetes stage, comorbidities and patient factors rather than one being superior.
全部药物对比